Morinda citrifolia-based formulation 5-LOX and 15-LOX

A method for inhibiting 5-Lipoxygenase, said method comprising the use of one or more Morinda citrifolia products.

A method for inhibiting 15-Lipoxygenase, said method comprising the use of one or more Morinda citrifolia products.

A method for inhibiting the oxygenation of arachidonic acid into its intermediate constituents, said method comprising the steps of:

• adding a Morinda citrifolia product to an alcohol-based solution;
• isolating and extracting an active ingredient of said processed Morinda citrifolia product from said solution to obtain a fraction;
• introducing said extracted active ingredient into or onto said mammal, wherein said extracted active ingredient inhibits oxygenation of arachidonic acid into its intermediate constituents.

The method claim of 25, wherein inhibiting the oxygenation of arachidonic acid is affected by inhibiting 5-lipoxygenase

The method claim of 25, wherein inhibiting the oxygenation of arachidonic acid is affected by inhibiting 15-lipoxygenase.

A method for inhibiting the oxygenation of arachidonic acid into its intermediate constituents, said method comprising the use of one or more Morinda citrifolia products.

The method claim of 37, wherein said inflammatory disease is treated by inhibiting 5-Lipoxygenase.

The method claim of 37, wherein said inflammatory disease is treated by inhibiting 15-Lipoxygenase.

A method for preventing and/or treating diseases within a mammal by inhibiting lipoxygenases, said method comprising the steps of:

• adding a processed Morinda citrifolia product to an alcohol-based solution;
• isolating and extracting an active ingredient of said processed Morinda citrifolia product from said solution to obtain a fraction;
• introducing said extracted active ingredient into and/or onto said mammal, wherein said extracted active ingredient inhibits, prevents, reduces, and reverses the effects of said disease.

The method claim of 47, wherein said disease is treated by inhibiting 5-Lipoxygenase.

The method claim of 47, wherein said disease is treated by inhibiting 15-Lipoxygenase.

A method for preventing and/or treating mammalian diseases by inhibiting one or more lipoxygenase enzyme, said method comprising the step of introducing one or more Morinda citrifolia product and/or extracted ingredient into and/or onto said mammal, wherein said product or extract inhibits, prevents, reduces, and reverses the effects of said disease.

The method claim of 60, wherein said disease is treated by inhibiting 5-Lipoxygenase.

The method claim of 60, wherein said disease is treated by inhibiting 15-Lipoxygenase.

A method for preventing and/or treating mammalian inflammatory diseases by inhibiting one or more lipoxygenase enzyme, said method comprising the steps of:

• introducing one or more Morinda citrifolia product and/or extracted ingredient into and/or onto said mammal, wherein said product or extract inhibits, prevents, reduces, and/or reverses the effects of said inflammatory disease.

The method claim of 72, wherein said inflammatory disease is treated by inhibiting 5-Lipoxygenase.

The method claim of 72, wherein said inflammatory disease is treated by inhibiting 15-Lipoxygenase.

An Lipoxygenase inhibitor for treating diseases and symptoms in mammals comprising a naturaceutical composition comprising at least one processed Morinda citrifolia product.

A method for regulating the oxidation of arachidonic acid within the body of a mammal for the treatment of inflammatory diseases, said method comprising the step of introducing a composition comprising a Morinda citrifolia product into or onto said mammal.

A method for regulating mammalian cell functioning by inhibiting one or more lipoxygenase enzyme, said method comprising the step of introducing one or more Morinda citrifolia product and/or extracted ingredient into and/or onto said mammal.